Articles Referencing STS

Threshold Cuts Loss, Misses Sales - Analyst Blog

3/13/2013, 9:10 am from Zacks.com in Investing, Business, Stocks

Threshold Pharmaceuticals Inc. ( THLD ) reported fourth-quarter 2012 net loss per share of 10 cents, narrower than the Zacks Consensus Estimate of a loss of 12 cents and the year-ago loss... Read >>

Threshold/Merck KGaA Drug in Study - Analyst Blog

1/29/2013, 4:15 pm from Zacks.com in Investing, Business, Stocks

Threshold Pharmaceuticals, Inc. ( THLD ) and Merck KGaA ( MKGAF ) recently announced the commencement of a global phase III study (MAESTRO) on their hypoxia-targeted candidate, TH-302.... Read >>